EUCTR2009-014452-30-NL进行中(未招募)不适用
Safety and efficacy of the addition of simvastatin to panitumumab in k-ras mutant advanced or metastatic colorectal cancer patients.A single-arm, multicenter, phase II study using a Simon two stage design. - RASTAT-P
Academisch ziekenhuis Leiden acting under the name of Leids Universitair Medisch Centrum0 个研究点开始时间: 2009年10月29日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中(未招募)
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Advanced or metastatic colorectal cancer failing prior 5FU, oxaliplatin and irinotecan
- •Mutation in codon 12, 13 or 61 of k-ras gene on tumor sample
- •Adequate condition (WHO 0-2)
- •Adequate organ function
- •Written informed consent
- •Age = 18 years
- •Progressive disease in the past 3 months
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Prior EGFr inhibiting therapy
- •Symptomatic brain metastasis
- •Using verapamil or amiodaron
- •Symptomatic hypothyroidism
- •History of interstitial lung disease
- •History of toxicity during statin use
研究者
相似试验
进行中(未招募)
不适用
Safety and efficacy of the addition of simvastatin to cetuximab in k-ras mutant advanced or metastatic colorectal cancer patients.A single-arm, multicenter, phase II study using a Simon two stage design. - RASTAT-Ck-ras mutant advanced or metastatic colorectal cancer failing prior 5-FU, oxaliplatin, and irinotecan containing regimens.MedDRA version: 12.1Level: LLTClassification code 10061451Term: Colorectal cancerEUCTR2009-017384-42-NLAcademisch ziekenhuis Leiden acting under the name of Leids Universitair Medisch Centrum
已完成
2 期
Safety and efficacy of the addition of simvastatin to cetuximab in k-ras mutant advanced or metastatic colorectal cancer patients. A single-arm, multicenter, phase II study using a Simon two stage design.colorectal cancerNL-OMON35030eids Universitair Medisch Centrum46
招募中
不适用
Effect if Simvastatin (Drug) in Liver CirrhosisCTRI/2021/12/038917Institute of Liver and Biliary Sciences
招募中
2 期
Protective effect of simvastatin on inflammatory factorIRCT20200421047152N3Iran University of Medical Sciences84
招募中
2 期
Effect of simvastatin in treatment of pachyonychia congenitaIRCT20160320027109N3Shahid Beheshti University of Medical Sciences20
